Sana Biotechnology Inc

NASDAQ: SANA
$2.40
-$0.13 (-5.1%)
Real Time Data Delayed 15 Min.

SANA Stock Chart and Intraday Price

SANA Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address 188 EAST BLAINE STREET, SUIT 400, SEATTLE, WA, US
Fiscal Year End December
Latest Quarter 9/30/2023
Market Cap 2,467.97M USD
Shares Outstanding 218,986,000
Sana Biotechnology Inc is at the forefront of biotechnology, focusing on turning engineered cells into innovative medicines. The company is pioneering in areas such as oncology, diabetes, and central nervous system disorders, aiming to address unmet treatment needs. With a robust pipeline including therapies for hematologic malignancies, non-Hodgkin’s lymphoma, multiple autoimmune disorders, and diabetes, Sana is leveraging cutting-edge technologies like CRISPR for cell therapy product development. Founded in 2018 and based in Seattle, Washington, Sana is committed to transforming the therapeutic landscape.

SANA Articles

Insider Buying: Taking a Controlling Stake in a Struggling Retailer?
A beneficial owner stepped up and took a controlling stake in a struggling retailer, while public offerings of stock prompted insider buying at some biotech companies.
Trey Thoelcke
Published: